Distinguished in Dihydropyrimidine Dehydrogenase Deficiency

Maarten J. Deenen

Leiden, ZH, NL 
Distinguished in Dihydropyrimidine Dehydrogenase Deficiency
Leiden, ZH, NL 
OverviewLocationsClinical Research

Overview

Maarten Deenen practices in Leiden, Netherlands. Mr. Deenen is rated as a Distinguished expert by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. His top areas of expertise are Dihydropyrimidine Dehydrogenase Deficiency, Agranulocytosis, Colorectal Cancer, and Febrile Neutropenia.

His clinical research consists of co-authoring 79 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Dihydropyrimidine Dehydrogenase Deficiency.

Gender
Male

Locations

Leiden, ZH, Netherlands
Other Locations
Zwolle, OV, Netherlands
Eindhoven, NB, Netherlands
Rijnstate
Arnhem, GE, Netherlands
Amsterdam, NH 1066CX, Netherlands
Smilde, DR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Repetitive Electrostatic Pressurised Intraperitoneal Aerosol Chemotherapy With Oxaliplatin (ePIPAC-OX) as a Palliative Monotherapy for Isolated Unresectable Colorectal Peritoneal Metastases: Protocol of a Multicentre, Open-label, Single-arm, Phase II Study (CRC-PIPAC)
Repetitive Electrostatic Pressurised Intraperitoneal Aerosol Chemotherapy With Oxaliplatin (ePIPAC-OX) as a Palliative Monotherapy for Isolated Unresectable Colorectal Peritoneal Metastases: Protocol of a Multicentre, Open-label, Single-arm, Phase II Study (CRC-PIPAC)
Enrollment Status: Completed
Publish Date: October 15, 2019
Intervention Type: Combination product
Study Phase: Phase 2

79 Total Publications

Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction.
Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction.
Journal: JCO precision oncology
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Deenen's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile